Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2975 of 3284 entries
View as:

Renal Impairment in Type 2 Diabetic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00554450 Org: User:
Start: 03/31/06 End: 10/31/08 Due: 10/31/09

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01548287 Org: User:
Start: 04/30/12 End: 01/31/13 Due: 01/31/14

Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients

Phase: N/A Priority: Normal
NCT ID: NCT00254748 Org: User:
Start: 06/30/04 End: 06/30/07 Due: 06/30/08

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Phase: N/A Priority: Normal
NCT ID: NCT06626945 Org: User:
Start: 02/03/25 End: 06/05/25 Due: 06/05/26

REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Phase: N/A Priority: Normal
NCT ID: NCT06826677 Org: User:
Start: 07/30/24 End: 01/23/25 Due: 01/23/26

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.

Phase: N/A Priority: Normal
NCT ID: NCT06916806 Org: User:
Start: 05/01/25 End: 08/05/27 Due: 08/05/28

Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00878501 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10

A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04232345 Org: User:
Start: 01/16/20 End: 03/11/21 Due: 03/11/22

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

Phase: N/A Priority: Normal
NCT ID: NCT01694758 Org: User:
Start: 11/30/12 End: 03/31/14 Due: 03/31/15

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01604733 Org: User:
Start: 10/31/10 End: 06/30/11 Due: 06/30/12

Lung Deposition Via Different Inhalation Devices

Phase: N/A Priority: Normal
NCT ID: NCT00975754 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Phase: N/A Priority: Normal
NCT ID: NCT00473616 Org: User:
Start: 05/31/07 End: 01/31/11 Due: 01/31/12

A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01739647 Org: User:
Start: 12/31/12 End: 05/31/13 Due: 05/31/14

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02093728 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05592483 Org: User:
Start: 07/07/23 End: 05/29/24 Due: 05/29/25

Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05203458 Org: User:
Start: 02/24/22 End: 07/05/23 Due: 07/05/24

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00243347 Org: User:
Start: 12/31/05 End: 07/31/09 Due: 07/31/10

A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT02579226 Org: User:
Start: 10/28/15 End: 04/03/20 Due: 04/03/21

A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03420092 Org: User:
Start: 02/05/18 End: 04/18/18 Due: 04/18/19

Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01096940 Org: User:
Start: 03/31/10 End: 08/31/10 Due: 08/31/11

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

Phase: N/A Priority: Normal
NCT ID: NCT01577563 Org: User:
Start: 05/31/12 End: 03/31/13 Due: 03/31/14

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01551888 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00894426 Org: User:
Start: 05/31/09 End: 12/31/09 Due: 12/31/10

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Phase: N/A Priority: Normal
NCT ID: NCT04078126 Org: User:
Start: 09/10/19 End: 12/30/20 Due: 12/30/21

Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05103605 Org: User:
Start: 05/12/21 End: 01/15/26 Due: 01/15/27